Insider · CIK 0001868494

Tingley Whittemore

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001868494

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-10	TNYATenaya Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+49K sh	—	—	263,073
2026-09-10	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Chief Medical Officer	AAward	+293K sh	—	—	293,000
2026-08-17	TNYATenaya Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,637 sh	$0.71	−$1,161.943	219,860
2026-08-17	TNYATenaya Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,637 sh	$0.71	−$1,161.943	218,223
2026-08-17	TNYATenaya Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,871 sh	$0.71	−$1,328.036	216,352
2026-08-17	TNYATenaya Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,279 sh	$0.71	−$1,617.634	214,073
2026-05-18	TNYATenaya Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−3,121 sh	$0.79	−$2,476.826	215,497
2026-02-17	TNYATenaya Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,642 sh	$0.64	−$1,056.134	222,136
2026-02-17	TNYATenaya Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,642 sh	$0.64	−$1,056.134	220,494
2026-02-17	TNYATenaya Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,876 sh	$0.64	−$1,206.456	218,618
2026-02-03	TNYATenaya Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+48.8K sh	—	—	223,778
2026-02-03	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Chief Medical Officer	AAward	+319K sh	—	—	318,500
2025-11-17	TNYATenaya Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,877 sh	$1.33	−$3,826.41	169,926
2025-08-18	TNYATenaya Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,608 sh	$1.25	−$2,014.824	176,248
2025-08-18	TNYATenaya Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,608 sh	$1.25	−$2,014.824	174,640
2025-08-18	TNYATenaya Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,837 sh	$1.25	−$2,301.761	172,803
2025-05-16	TNYATenaya Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−2,937 sh	$0.44	−$1,300.21	171,856
2025-03-10	TNYATenaya Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,727 sh	$0.54	−$929.817	180,464
2025-03-10	TNYATenaya Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−4,073 sh	$0.54	−$2,192.903	176,391
2025-03-10	TNYATenaya Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,598 sh	$0.54	−$860.363	174,793
2025-01-24	TNYATenaya Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+40K sh	—	—	147,106
2025-01-24	TNYATenaya Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+31.7K sh	—	—	178,782
2025-01-24	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Chief Medical Officer	AAward	+235K sh	—	—	235,000
2025-01-24	TNYATenaya Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−70K sh	—	—	0
2025-01-24	TNYATenaya Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+70K sh	—	—	69,982
2025-01-24	TNYATenaya Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−141K sh	—	—	0
2025-01-24	TNYATenaya Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+141K sh	—	—	141,000
2025-01-24	TNYATenaya Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−205K sh	—	—	0
2025-01-24	TNYATenaya Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+205K sh	—	—	205,000
2025-01-24	TNYATenaya Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−215K sh	—	—	0
2025-01-24	TNYATenaya Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+215K sh	—	—	215,000
2024-08-16	TNYATenaya Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−5,803 sh	$2.89	−$16.8K	108,731
2024-08-16	TNYATenaya Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−1,625 sh	$2.89	−$4,703.563	107,106
2024-02-23	TNYATenaya Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+35K sh	—	—	108,534
2024-02-23	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Chief Medical Officer	AAward	+215K sh	—	—	215,000
2024-02-16	TNYATenaya Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−6,500 sh	$5.86	−$38.1K	73,534
2023-08-16	TNYATenaya Therapeutics, Inc.S Sale	Chief Medical Officer	SSale	−5,563 sh	$3.81	−$21.2K	76,437
2023-02-15	TNYATenaya Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+35K sh	—	—	35,000
2023-02-15	TNYATenaya Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+45K sh	—	—	80,000
2023-02-15	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Chief Medical Officer	AAward	+205K sh	—	—	205,000
2022-02-15	TNYATenaya Therapeutics, Inc. · Stock Option (Right to buy)A Award	Chief Medical Officer	AAward	+141K sh	—	—	141,000

Recent filings

Accepted (ET)
Sep 114
Tingley Whittemore0001193125-26-389561
SEC(opens sec.gov)
Aug 174
Tingley Whittemore0001193125-26-354517
SEC(opens sec.gov)
May 194
Tingley Whittemore0001193125-26-231323
SEC(opens sec.gov)
Feb 174
Tingley Whittemore0001193125-26-055439
SEC(opens sec.gov)
Feb 54
Tingley Whittemore0001193125-26-039763
SEC(opens sec.gov)
Nov 174
Tingley Whittemore0001193125-25-284997
SEC(opens sec.gov)
Aug 184
Tingley Whittemore0001868494-25-000006
SEC(opens sec.gov)
May 164
Tingley Whittemore0000950170-25-073824
SEC(opens sec.gov)
Mar 104
Tingley Whittemore0000950170-25-036772
SEC(opens sec.gov)

Companies

Tenaya Therapeutics, Inc.Chief Medical OfficerTNYA

Address

C/O TENAYA THERAPEUTICS, INC. 171 OYSTER POINT BLVD., 5TH FLOOR

SOUTH SAN FRANCISCO, CA, 94080